Skip to main content
. 2015 Feb 17;50(7):824–831. doi: 10.3109/00365521.2015.1010571

Table II.

Characteristics of 56 celiac disease antibody-positive participants according to whether they were diagnosed with celiac disease or not.

    Participants who completed clinical evaluation and biopsy
All antibody-positive participants Celiac disease not confirmed Diagnosed with celiac disease
Number 56 32 8
Mean age in years 55.8 (26–74) 56.3 (26–74) 53.3 (29–73)
Antibody positivity      
 IgA-TTG 13 (23.2) 2 (6.3) 7 (87.5)
 IgA-DGP 47 (83.9) 27 (84.4) 5 (62.5)
 IgG-DGP 12 (21.4) 5 (15.6) 5 (62.5)
 IgG-TTG 0 (0) 0 (0) 0 (0)
HLA type      
 + DQ2/ − DQ8 28 (50.0) 14 (43.8) 6 (75.0)
 + DQ2/ + DQ8 4 (7.1) 2 (6.3) 2 (25.0)
 − DQ2/ + DQ8 8 (14.3) 5 (15.6) 0 (0)
 − DQ2/ − DQ8 16 (28.6) 11 (34.4) 0 (0)
Marsh classification      
 0 - 30 (93.8) 0 (0)
 1 - 2 (6.3) 1 (12.5)
 2 - 0 (0) 0 (0)
 3A - 0 (0) 2 (25.0)
 3B - 0 (0) 3 (37.5)
 3C - 0 (0) 2 (25.0)
Breath tests      
 Lactose intolerance - 1 0
 Glucose intolerance - 0 0
BMD n = 33 n = 26 n = 7
Total lumbar spine      
t-score - −0.27 (1.82) −0.16 (1.60)
 BMD (g/cm2) - 1.04 (0.20) 1.05 (0.18)
Total left hip      
t-score - −0.50 (1.13) −0.21 (0.78)
 BMD (g/cm2) - 0.93 (0.17) 0.95 (0.10)
Total right hip      
t-score - −0.52 (1.12) −0.16 (0.97)
 BMD (g/cm2) - 0.92 (0.16) 0.96 (0.13)
Osteoporosis      
 Osteoporosis - 3 0
 Osteopenia - 9 2

Abbreviations: BMD = Bone mineral density; HLA = Human lymphocyte antigen; IgA-TTG = IgA antibody to tissue transglutaminase; IgA-DGP = IgA to deamidated gliadin peptide; IgG-DGP = IgG to deamidated gliadin peptide.